TY - BOOK PY - 1998 DA - 1998// TI - Indicatori farmaceutici PB - Rome CY - Farmindustria ID - ref1 ER - TY - JOUR AU - Gagnon, M. -. A. AU - Lexchin, J. PY - 2008 DA - 2008// TI - The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States JO - PLoS Med VL - 5 UR - https://doi.org/10.1371/journal.pmed.0050001 DO - 10.1371/journal.pmed.0050001 ID - Gagnon2008 ER - TY - JOUR AU - Boltri, J. M. AU - Gordon, E. R. AU - Vogel, R. L. PY - 2002 DA - 2002// TI - Effect of antihypertensive samples on physician prescribing patterns JO - Fam Med VL - 34 ID - Boltri2002 ER - TY - JOUR AU - Spurling, G. K. AU - Mansfield, P. R. AU - Montgomery, B. D. AU - Lexchin, J. AU - Doust, J. AU - Othman, N. AU - Vitry, A. I. PY - 2010 DA - 2010// TI - Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review JO - PLoS Med VL - 7 UR - https://doi.org/10.1371/journal.pmed.1000352 DO - 10.1371/journal.pmed.1000352 ID - Spurling2010 ER - TY - JOUR AU - Wall, L. L. AU - Brown, D. PY - 2007 DA - 2007// TI - The high cost of free lunch JO - Obstet Gynecol VL - 110 UR - https://doi.org/10.1097/01.AOG.0000268800.46677.14 DO - 10.1097/01.AOG.0000268800.46677.14 ID - Wall2007 ER - TY - JOUR AU - Othman, N. AU - Vitry, A. I. AU - Roughead, E. E. PY - 2007 DA - 2007// TI - Quality of pharmaceutical advertisements in medical journals: a systematic review JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0006350 DO - 10.1371/journal.pone.0006350 ID - Othman2007 ER - TY - BOOK AU - Findlay, S. PY - 2000 DA - 2000// TI - Prescription drugs and mass media advertising PB - National Institute for Health Care Management Research and Educational Foundation CY - Washington D.C. ID - Findlay2000 ER - TY - BOOK AU - Mintzes, B. PY - 2006 DA - 2006// TI - What are the public health implications? Direct-to-consumer advertising of prescription drugs in Canada PB - Health Council of Canada CY - Toronto ID - Mintzes2006 ER - TY - JOUR AU - Kravitz, R. L. AU - Epstein, R. M. AU - Feldman, M. D. AU - Franz, C. E. AU - Azari, R. AU - Wilkes, M. S. AU - Hinton, L. AU - Franks, P. PY - 2005 DA - 2005// TI - Influence of patients’ requests for direct-to-consumer advertised antidepressants: a randomized controlled trial JO - JAMA VL - 293 UR - https://doi.org/10.1001/jama.293.16.1995 DO - 10.1001/jama.293.16.1995 ID - Kravitz2005 ER - TY - BOOK AU - Evans, D. PY - 2009 DA - 2009// TI - Big Pharma’s crime spree ID - Evans2009 ER - TY - JOUR AU - Spielmans, G. I. PY - 2009 DA - 2009// TI - The promotion of olanzapine in primary care: an examination of internal industry documents JO - Soc Sci Med VL - 69 UR - https://doi.org/10.1016/j.socscimed.2009.05.001 DO - 10.1016/j.socscimed.2009.05.001 ID - Spielmans2009 ER - TY - JOUR AU - Rochon, P. A. AU - Normand, S. -. L. AU - Gomes, T. AU - Gill, S. S. AU - Anderson, G. M. AU - Melo, M. AU - Skykora, K. AU - Lipscombe, L. AU - Bell, C. M. AU - Gurwitz, J. H. PY - 2008 DA - 2008// TI - Antipsychotic therapy and short-term serious events in older adults with dementia JO - Arch Intern Med VL - 168 UR - https://doi.org/10.1001/archinte.168.10.1090 DO - 10.1001/archinte.168.10.1090 ID - Rochon2008 ER - TY - JOUR AU - Landefeld, C. S. AU - Steinman, M. A. PY - 2009 DA - 2009// TI - The Neurontin legacy - marketing through misinformation and manipulation JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMp0808659 DO - 10.1056/NEJMp0808659 ID - Landefeld2009 ER - TY - BOOK PY - 2006 DA - 2006// TI - Prescription drugs: improvements needed in FDA's oversight of direct-to-consumer advertising ID - ref14 ER - TY - BOOK PY - 2008 DA - 2008// TI - Prescription drugs: trends in FDA's oversight of direct-to-consumer advertising ID - ref15 ER - TY - BOOK PY - 2011 DA - 2011// TI - DDMAC submissions ID - ref16 ER - TY - BOOK AU - Thaul, S. PY - 2009 DA - 2009// TI - Direct-to-consumer advertising of prescription drugs ID - Thaul2009 ER - TY - BOOK PY - 2008 DA - 2008// TI - Prescription drugs: FDA’s oversight of the promotion of drugs for off-label uses ID - ref18 ER - TY - BOOK PY - 2011 DA - 2011// TI - Prescription Medicines Code of Practice Authority: Annual Report 2010 ID - ref19 ER - TY - CHAP AU - Lexchin, J. AU - Kawachi, I. ED - Davis, P. PY - 1996 DA - 1996// TI - Voluntary codes of pharmaceutical marketing: controlling promotion or licensing deception BT - Contested ground: public purpose and private interest in the regulation of prescription drugs PB - New York CY - Oxford University Press ID - Lexchin1996 ER - TY - CHAP AU - Ziganshina, L. AU - Lexchin, J. ED - Mintzes, B. ED - Mangin, D. ED - Hayes, L. PY - 2009 DA - 2009// TI - Regulation of pharmaceutical promotion: why does regulation matter BT - Understanding and responding to pharmaceutical promotion: a practical guide PB - Geneva and Amsterdam CY - World Health Organization/Health Action International ID - Ziganshina2009 ER - TY - STD TI - Health Action International: http://www.haiweb.org/, UR - http://www.haiweb.org/ ID - ref22 ER - TY - JOUR AU - Carpenter, D. AU - Zucker, E. J. AU - Avorn, J. PY - 2008 DA - 2008// TI - Drug-review deadlines and safety problems JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMsa0706341 DO - 10.1056/NEJMsa0706341 ID - Carpenter2008 ER - TY - BOOK PY - 2007 DA - 2007// TI - Cost recovery framework: official notice of fee proposal for human drugs and medical devices ID - ref24 ER - TY - BOOK PY - 2009 DA - 2009// TI - Code of Advertising Acceptance PB - Pickering CY - Pharmaceutical Advertising Advisory Board ID - ref25 ER - TY - JOUR PY - 2010 DA - 2010// TI - Feasiblity and challenges of independent research on drugs: the Italian Medicines Agency (AIFA) experience JO - Eur J Clin Invest VL - 40 UR - https://doi.org/10.1111/j.1365-2362.2009.02226.x DO - 10.1111/j.1365-2362.2009.02226.x ID - ref26 ER - TY - BOOK AU - Ayres, I. AU - Braithwaite, J. PY - 1992 DA - 1992// TI - Responsive regulation. Transcending the deregulation debate PB - New York CY - Oxford University Press ID - Ayres1992 ER -